Keyur Parikh
Keyur Parikh
Care Institute of Medical Sciences
Verified email at cims.org
Title
Cited by
Cited by
Year
Platelet inhibition with cangrelor in patients undergoing PCI
RA Harrington, GW Stone, S McNulty, HD White, AM Lincoff, CM Gibson, ...
New England Journal of Medicine 361 (24), 2318-2329, 2009
6562009
Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes (PLATO) trial
S James, A Budaj, P Aylward, KK Buck, CP Cannon, JH Cornel, ...
Circulation 122 (11), 1056-1067, 2010
4562010
Efficacy and safety of oral treprostinil monotherapy for the treatment of pulmonary arterial hypertension: a randomized, controlled trial
ZC Jing, K Parikh, T Pulido, C Jerjes-Sanchez, RJ White, R Allen, ...
Circulation 127 (5), 624-633, 2013
3162013
Exercise improvement and plasma biomarker changes with intravenous treprostinil therapy for pulmonary arterial hypertension: a placebo-controlled trial
J Hiremath, S Thanikachalam, K Parikh, S Shanmugasundaram, ...
The Journal of heart and lung transplantation 29 (2), 137-149, 2010
2012010
Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label …
E Camenzind, W Wijns, L Mauri, V Kurowski, K Parikh, R Gao, C Bode, ...
The Lancet 380 (9851), 1396-1405, 2012
1632012
Coronary sinus reducer stent for the treatment of chronic refractory angina pectoris: a prospective, open-label, multicenter, safety feasibility first-in-man study
S Banai, S Ben Muvhar, KH Parikh, A Medina, H Sievert, A Seth, J Tsehori, ...
Journal of the American College of Cardiology 49 (17), 1783-1789, 2007
1262007
Safety and feasibility of orbital atherectomy for the treatment of calcified coronary lesions: the ORBIT I trial
K Parikh, P Chandra, N Choksi, P Khanna, J Chambers
Catheterization and Cardiovascular Interventions 81 (7), 1134-1139, 2013
952013
Systematic primary aspiration in acute myocardial percutaneous intervention: a multicentre randomised controlled trial of the export aspiration catheter.
B Chevalier, M Gilard, I Lang, P Commeau, J Roosen, M Hanssen, ...
EuroIntervention: journal of EuroPCR in collaboration with the Working Group …, 2008
802008
Endeavour zotarolimus-eluting stent reduces stent thrombosis and improves clinical outcomes compared with cypher sirolimus-eluting stent: 4-year results of the PROTECT …
W Wijns, PG Steg, L Mauri, V Kurowski, K Parikh, R Gao, C Bode, ...
European heart journal 35 (40), 2812-2820, 2014
612014
Modifying effect of dual antiplatelet therapy on incidence of stent thrombosis according to implanted drug-eluting stent type
E Camenzind, E Boersma, W Wijns, L Mauri, T Rademaker-Havinga, ...
European heart journal 35 (29), 1932-1948, 2014
552014
Rationale and design of the Patient Related OuTcomes with Endeavor versus Cypher stenting Trial (PROTECT): randomized controlled trial comparing the incidence of stent …
E Camenzind, W Wijns, L Mauri, E Boersma, K Parikh, V Kurowski, R Gao, ...
American heart journal 158 (6), 902-909. e5, 2009
512009
Wireless acoustic communication with a miniature pressure sensor in the pulmonary artery for disease surveillance and therapy of patients with congestive heart failure
Y Rozenman, RS Schwartz, H Shah, KH Parikh
Journal of the American College of Cardiology 49 (7), 784-789, 2007
492007
Intracoronary boluses of adenosine and sodium nitroprusside in combination reverses slow/no-reflow during angioplasty: a clinical scenario of ischemic preconditioning
KH Parikh, MC Chag, KJ Shah, UG Shah, HA Baxi, AH Chandarana, ...
Canadian journal of physiology and pharmacology 85 (3-4), 476-482, 2007
452007
Cangrelor with and without glycoprotein IIb/IIIa inhibitors in patients undergoing percutaneous coronary intervention
M Vaduganathan, RA Harrington, GW Stone, EN Deliargyris, PG Steg, ...
Journal of the American College of Cardiology 69 (2), 176-185, 2017
442017
Effect of diltiazem on renal clearance and serum concentration of digoxin in patients with cardiac disease
U Elkayam, K Parikh, B Torkan, L Weber, JL Cohen, SH Rahimtoola
The American journal of cardiology 55 (11), 1393-1395, 1985
411985
Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED‐HF)
JJV McMurray, IS Anand, R Diaz, AP Maggioni, C O'Connor, MA Pfeffer, ...
European journal of heart failure 15 (3), 334-341, 2013
332013
Orbital atherectomy system in treating calcified coronary lesions: 3-year follow-up in first human use study (ORBIT I trial)
P Bhatt, P Parikh, A Patel, M Chag, A Chandarana, R Parikh, K Parikh
Cardiovascular Revascularization Medicine 15 (4), 204-208, 2014
292014
Long-term safety and performance of the orbital atherectomy system for treating calcified coronary artery lesions: 5-Year follow-up in the ORBIT I trial
P Bhatt, P Parikh, A Patel, M Chag, A Chandarana, R Parikh, K Parikh
Cardiovascular Revascularization Medicine 16 (4), 213-216, 2015
252015
Extended follow‐up safety and effectiveness of the Endeavor zotarolimus‐eluting stent in real‐world clinical practice: Two‐year follow‐up from the E‐Five Registry
I Meredith, M Rothman, A Erglis, K Parikh, C Lotan, E‐Five Investigators
Catheterization and Cardiovascular Interventions 77 (7), 993-1000, 2011
202011
Long-Term follow-up to evaluate the safety of the NEOVASC reducer a DEVICE-BASED therapy for chronic refractory angina
S Banai, M Schwartz, H Sievert, A Seth, G Keren, KH Parikh
Journal of the American College of Cardiology 55 (10S), A98. E927-A98. E927, 2010
192010
The system can't perform the operation now. Try again later.
Articles 1–20